Grand Opening of “National Marine Economic Innovation and Development (Beihai) Industrial Park and Beihai Sinlon Chinese Horseshoe Crabs Marine Medicine Industrial Park”

On June 28, the “National Marine Economic Innovation and Development (Beihai) Industrial Park and Beihai Sinlon Chinese Horseshoe Crab Marine Biomedicine Industrial Park” invested and constructed by Tianjin Era Biology Technology Co., Ltd.  was successfully completed in Beihai, Guangxi, and the opening ceremony was successfully held.

Grand Opening of "National Marine Economic Innovation and Development (Beihai) Industrial Park and Beihai Sinlon Chinese Horseshoe Crabs Marine Medicine Industrial Park"

The park is constructed and operated by Beihai Sinlon Biotech Co., Ltd., a wholly-owned subsidiary of Era Biology Group. After a year and a half of orderly and intense construction period, the park will officially open for operation on June 28, 2021.
Grand Opening of "National Marine Economic Innovation and Development (Beihai) Industrial Park and Beihai Sinlon Chinese Horseshoe Crabs Marine Medicine Industrial Park"

President He of Era Biology Group made the following speech at the opening ceremony:

Sinlon Biotech settled in the industrial park in 2001. From project approval and site selection to construction preparations, the park has received great attention and strong support from the Ministry of Natural Resources, Guangxi Autonomous Region, Beihai City governments at all levels, and the industrial park management committee. Sinlon Biotech is fortunate to undertake the national “13th Five-Year” marine innovation demonstration industrial chain project. The project has been rated as a key project of the Guangxi Autonomous Region “Biomedicine Industry 100 Billion Tackling Toughness” and a major project for “double new” coordinated promotion, and has been listed “Three-year Action Plan 2020-2022 for the Construction of Guangxi’s Strong Marine Economic Zone.”

At the beginning of the construction of the park, the concept of “atmosphere and practicality, simplicity and refinement, and ocean technology” was established. Relying on the unique high-quality marine resources of the North Bay, Sinlon Biotech closely follows the Party Central Committee and the State Council’s strategic policy on the development of “sea-oriented economy”, based on scientific research, staying in the ecology, and giving full play to its advanced marine biotechnology to develop the medicinal value of marine biology in the North Bay. With innovation as the goal of unremitting pursuit, the park has built a comprehensive “Marine Biomedicine Industrial Park” integrating marine biomedicine development, Chinese horseshoe crab breeding, research and development and production of diagnostic reagents and instruments, and marine science education. It has a complete industrial chain integrating biological resource protection, raw material preparation, diagnostic reagents + fully automatic instrument research and development, production, and global sales and services. Through years of cooperative research with Shanghai Ocean University, Sinlon has formed a set of corporate standards for Chinese horseshoe crab simulated natural aquaculture, artificial seedlings, live blood collection, optimal recovery after blood collection, and disease prevention. The annual artificial reproduction and release of 200,000 young horseshoe crabs over 3 years old is expected to gradually restore the population of horseshoe crabs in the North Bay through continuous breeding and release work each year. At the same time, through standard blood collection, recovery after blood collection and legal release, the two-pronged, sustainable protection and use of Chinese horseshoe crab resources is realized.


Post time: Jun-30-2021